Amgen Inc. AMGN
NASDAQ · United States · Health Technology
$421.51-2.13 (-0.50%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | 6.29 | 5.62 | +12.0% | $10.05B | +6.7% | +7.6%$378.87→$407.83 |
| Q1 2026 | 2026-04-30 | 5.15 | 4.77 | +8.0% | — | — | -2.4%$338.02→$329.82 |
| Q4 2025 | 2026-02-03 | 5.29 | 4.73 | +11.8% | — | — | +6.2%$344.68→$366.20 |
| Q3 2025 | 2025-11-04 | 5.64 | 5.01 | +12.6% | — | — | +8.0%$296.30→$319.86 |
| Q2 2025 | 2025-08-05 | 6.02 | 5.28 | +14.0% | — | — | — |
| Q1 2025 | 2025-05-01 | 4.90 | 4.26 | +15.0% | — | — | — |
| Q4 2024 | 2025-02-04 | 5.31 | 5.08 | +4.5% | — | — | — |
| Q3 2024 | 2024-10-30 | 5.58 | 5.11 | +9.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.